Form 8-K - Current report:
SEC Accession No. 0001140361-25-003762
Filing Date
2025-02-10
Accepted
2025-02-10 17:16:12
Documents
14
Period of Report
2025-02-04
Items
Item 1.02: Termination of a Material Definitive Agreement

Document Format Files

Seq Description Document Type Size
1 8-K ef20043253_8k.htm   iXBRL 8-K 26409
  Complete submission text file 0001140361-25-003762.txt   201817

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA bngo-20250204.xsd EX-101.SCH 4444
3 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE bngo-20250204_def.xml EX-101.DEF 17538
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE bngo-20250204_lab.xml EX-101.LAB 26356
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE bngo-20250204_pre.xml EX-101.PRE 19723
16 EXTRACTED XBRL INSTANCE DOCUMENT ef20043253_8k_htm.xml XML 6220
Mailing Address 9540 TOWNE CENTRE DRIVE SUITE 100 SAN DIEGO CA 92121
Business Address 9540 TOWNE CENTRE DRIVE SUITE 100 SAN DIEGO CA 92121 (858) 888-7600
Bionano Genomics, Inc. (Filer) CIK: 0001411690 (see all company filings)

EIN.: 261756290 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38613 | Film No.: 25606682
SIC: 3826 Laboratory Analytical Instruments
(CF Office: 08 Industrial Applications and Services)